Showing results (981-990 of 1,025) with videos related to
Sort By:
Pageof 103
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 13, 2023
Prospective Longitudinal Assessment of Quality of Life After Stereotactic Ablative Radiotherapy for Oligometastases: Analysis of the Population-based SABR-5 Phase II TrialE M Cruz-Lim, B Mou, S Baker, et al.Neurology|April 13, 2012
A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson diseaseI H Richard, M P McDermott, R Kurlan, et al.Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|January 12, 2018
[Qualitative pathological assessment of liver fibrosis regression after antiviral therapy in patients with chronic hepatitis B]Y M Sun, J L Zhou, L Wang, et al.Oncogene|July 25, 2012
Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomasP Wang, Q Dong, C Zhang, et al.Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|June 12, 2020
[The phenotypes and genotypes in 314 patients with isolated methylmalonic acidemia]L L Kang, Y P Liu, M Shen, et al.Journal of Medicinal Chemistry|February 20, 2009
Inhibitors of hepatitis C virus polymerase: synthesis and biological characterization of unsymmetrical dialkyl-hydroxynaphthalenoyl-benzothiadiazinesRolf Wagner, Daniel P Larson, David W A Beno, et al.Physical Review Letters|May 13, 2014
Observation of enhanced monopole strength and clustering in (12)BeZ H Yang, Y L Ye, Z H Li, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 17, 2017
[Distribution and drug resistance of pathogens at hematology department of Jiangsu Province from 2014 to 2015: results from a multicenter, retrospective study]Y K Wan, W Sang, B Chen, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2023
Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III studyX Q Yan, M J Ye, Q Zou, et al.Science Advances|December 5, 2019
Measurement of the cosmic ray proton spectrum from 40 GeV to 100 TeV with the DAMPE satellite, Q An, R Asfandiyarov, et al.Pageof 103